Plasticity

Ocean Biomedical (NASDAQ: OCEA) Announces New Glioblastoma Results Validating Profound Tumor Suppression with Anti-Chi3L1 Antibody

Retrieved on: 
Thursday, April 27, 2023

Providence, RI, April 27, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ: OCEA), a biopharma company working to accelerate the development and commercialization of scientifically compelling assets from research universities and medical centers, announced today that its Scientific Co-founder, Jack A. Elias, MD, published new findings in the peer-reviewed journal Cancer Research that detail the mechanisms behind the role of chitinase 3-like-1 (Chi3L1) in the growth of glioblastoma tumors, providing further evidence of the potential impact of Ocean’s anti-Chi3L1 antibody in suppressing severe glioblastoma tumor growth.

Key Points: 
  • In two different study approaches, treatment with anti-Chi3L1 antibody in vivo resulted in over 60% reduction of human glioblastoma growth, and significant survival benefit.
  • This represents a medical breakthrough in understanding how the most aggressive glioblastoma tumors are formed, and how patients diagnosed with this challenging disease might possibly be treated.
  • “This is a completely new way of thinking about how to treat this tumor.
  • Knowing the drivers for this heterogeneity, this is the holy grail for glioblastoma.”

YES Receives Repeat, Volume VertaCure Order from Major Foundry

Retrieved on: 
Wednesday, February 3, 2021

FREMONT, Calif., Feb. 3, 2021 /PRNewswire-PRWeb/ --YES ( Yield Engineering Systems, Inc. ), a leading manufacturer of process equipment for semiconductor advanced packaging, life sciences and AR/VR applications, today announced that it has received a repeat, volume purchase order from a leading foundry for its VertaCure polyimide curing system and its next-generation VertaCure XP system.

Key Points: 
  • FREMONT, Calif., Feb. 3, 2021 /PRNewswire-PRWeb/ --YES ( Yield Engineering Systems, Inc. ), a leading manufacturer of process equipment for semiconductor advanced packaging, life sciences and AR/VR applications, today announced that it has received a repeat, volume purchase order from a leading foundry for its VertaCure polyimide curing system and its next-generation VertaCure XP system.
  • This repeat order validates the superior technical performance and value of YES's VertaCure product offering for high-volume-manufacturing (HVM)," Chow added.
  • This substantial repeat order again confirms that YES is a valued and trusted partner in the production of cutting-edge technologies," said Rezwan Lateef, President of YES.
  • YES (Yield Engineering Systems, Inc.) is a leading manufacturer of high-tech, cost-effective equipment for transforming surfaces, materials and interfaces.

Micropillar compression for finding heat-tolerant alloys

Retrieved on: 
Wednesday, January 13, 2021

Now, scientists at Kyoto University in Japan have measured what happens at the micro-level when pressure is applied on tiny samples of these materials.

Key Points: 
  • Now, scientists at Kyoto University in Japan have measured what happens at the micro-level when pressure is applied on tiny samples of these materials.
  • The scientists measured the plastic deformation that happened when a tiny probe exerted force on the micropillar specimens with various loading axis orientations.
  • "Our results demonstrate the cutting edge of research into plastic deformation behaviour in crystalline materials," says Kyosuke Kishida, the study's corresponding author.
  • This could mean alpha-Nb5Si3 is at a disadvantage compared to Mo5SiB2 for use as a strengthening component in metal-based alloys.

Brain Health & Research Institute to Promote Brain Health Using BrainHQ

Retrieved on: 
Monday, June 10, 2019

BrainHQ is unique among brain training programs because of the deep science behind the product.

Key Points: 
  • BrainHQ is unique among brain training programs because of the deep science behind the product.
  • Studies also show structural changes in the brain, indicative of more efficient operations and improved brain health.
  • "BrainHQ is the culmination of decades of research in neuroscience and brain plasticity," said Dr. Henry Mahncke, CEO of Posit Science.
  • ISB is an affiliate of Providence St. Joseph Health, one of the largest not-for-profit health care systems in the United States.